Substance Use Disorder-Related Deaths and Maternal Mortality in New Mexico, 2015-2019

被引:1
|
作者
Fuchs, Jessica R. [1 ]
Schiff, Melissa A. [2 ]
Coronado, Eirian [1 ]
机构
[1] New Mexico Dept Hlth, 2040 S Pacheco St, Santa Fe, NM 87505 USA
[2] Univ New Mexico, Dept Internal Med, Sch Med, 1 Univ New Mexico, Albuquerque, NM 87131 USA
关键词
Maternal mortality; Substance use; Mental health; Pregnancy; Postpartum; RELAPSE; WOMEN;
D O I
10.1007/s10995-023-03691-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundIn recent decades, maternal mortality has increased across the U.S. Experiences of pregnant and postpartum people with Substance Use Disorder (SUD)-related deaths have not been previously evaluated in New Mexico. The aim of this study was to analyze risk factors related to substance use and explore substance use patterns among pregnancy-associated deaths in New Mexico from 2015 to 2019.MethodsWe conducted an analysis of pregnancy-associated deaths to assess the association between demographics, pregnancy factors, circumstances surrounding death, treatment of mental health conditions, and experiences with social stressors among Substance Use Disorder (SUD)-related and non-SUD-related deaths. We performed univariate analyses of risk factors using chi-square tests to assess the differences between SUD-related and non-SUD-related deaths. We also examined substance use at time of death.ResultsPeople with SUD-related deaths were more likely to die 43-365 days postpartum (81% vs. 45%, p-value = 0.002), have had a primary cause of death of mental health conditions (47% vs 10%, p < 0.001), have died of an overdose (41% vs. 8%, p-value = 0.002), have had experienced any social stressors (86% vs 30%, p < 0.001) compared to people with non-SUD-related deaths, and received treatment for SUD at any point before, during, or after pregnancy (49% vs. 2%, p < 0.001). The substances most used at time of death were amphetamines (70%), and most cases engaged in polysubstance use (63%).Conclusions for PracticeProviders, health departments, and community organizations must prioritize supporting people using substances during and after pregnancy to prevent death and improve quality of life for pregnant and postpartum people. SignificanceWhat is Already Known on this Subject? Maternal mortality rates have been increasing across the U.S. Substance use and overdoses are leading causes of death among pregnant and postpartum people. Return to use in the postpartum period following abstinence during pregnancy is common. New Mexico has some of the highest rates of death attributed to alcohol use, and experiences high rates of substance use.What does this study add? This study provides background on risk factors for Substance Use Disorder (SUD)-related death among pregnant and postpartum people in New Mexico. It explores experiences with mental health treatments and social stressors, and substance use patterns among pregnant and postpartum people with SUD-related deaths.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 47 条
  • [41] Availability of Trauma-Specific Services in US Substance Use Disorder and Other Mental Health Treatment Facilities: 2015–2019
    Stanislav Spivak
    Amethyst Spivak
    Michele R. Decker
    Bernadette Cullen
    Melissa Yao
    Ramin Mojtabai
    Psychiatric Quarterly, 2022, 93 : 703 - 715
  • [42] The burden of mental disorders in Mexico, 1990-2019: Mental and neurological disorders, substance use, suicides, and related somatic disorders
    Garcia-Pacheco, Jose angel
    Ortega, Maria de Lourdes Torres
    Borges, Guilherme
    SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH, 2024, 17 (02): : 64 - 70
  • [43] Association between functional disability type and suicide-related outcomes among US adults with disabilities in the National Survey on Drug Use and Health, 2015-2019
    Marlow, Nicole M.
    Xie, Zhigang
    Tanner, Rebecca
    Jacobs, Molly
    Hogan, Michaela K.
    Joiner Jr, Thomas E.
    V. Kirby, Anne
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 153 : 213 - 222
  • [44] The nationwide trends in hospital admissions, deaths, and costs related to hepatitis C stratified by psychiatric disorders and substance use: an analysis of US hospitals between 2016 and 2019
    Lee, David Uihwan
    Ponder, Reid
    Lee, Ki Jung
    Yoo, Ashley
    Fan, Gregory Hongyuan
    Jung, Daniel
    Chou, Harrison
    Lee, Keeseok
    Hofheinz, Olivia
    Urrunaga, Nathalie Helen
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (04) : 402 - 419
  • [45] Is severe maternal morbidity a risk factor for postpartum hospitalization with mental health or substance use disorder diagnoses? Findings from a retrospective cohort study in Maryland: 2016–2019
    Carrie L Wolfson
    Jessica Tsipe Angelson
    Andreea A Creanga
    Maternal Health, Neonatology and Perinatology, 11 (1)
  • [46] Trends, Gender, and Racial Disparities in Mortality Related to Liver Diseases Associated With Substance Use Disorder in the United States: A Retrospective Analysis from 1999 to 2020
    Rehman, Khawaja Abdul
    Fatima, Eeshal
    Hassan, Syed Adeel
    Rasheed, Waqas
    Altaf, Faryal
    Qureshi, Zaheer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1447 - S1448
  • [47] ELEVATED RISK FOR LIVER RELATED MORTALITY IN CHRONIC HEPATITIS C PATIENTS BOTH WITH OR WITHOUT ILLICIT SUBSTANCE USE DISORDER: A NATION-WIDE REGISTER STUDY
    Soderholm, Jonas
    Larsson, Simon B.
    Jerkeman, Anna
    Nystedt, Anders
    Duberg, Ann-Sofi
    Kovamees, Jan
    Ydreborg, Magdalena
    Aleman, Soo
    Busch, Katharina
    Blome, Marianne Alanko
    Weiland, Ola R.
    Kaberg, Martin
    HEPATOLOGY, 2019, 70 : 366A - 366A